LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.570
+0.040 (1.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
LakeShore Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 49 | 136 | 149 | 233 | - |
| Market Cap Growth | -8.94% | -8.94% | -36.17% | - | - |
| Enterprise Value | 75 | 176 | 408 | 373 | - |
| Last Close Price | 2.62 | 7.20 | 16.00 | 67.97 | - |
| PS Ratio | 0.35 | 1.71 | 1.49 | 2.94 | - |
| PB Ratio | 0.61 | 1.67 | 1.40 | 2.20 | - |
| P/TBV Ratio | 1.90 | 1.90 | 1.57 | - | - |
| EV/Sales Ratio | 0.94 | 2.22 | 4.08 | 4.70 | - |
| Debt / Equity Ratio | 0.73 | 0.73 | 0.68 | 0.57 | 0.02 |
| Asset Turnover | 0.35 | 0.35 | 0.43 | 0.39 | - |
| Inventory Turnover | 0.94 | 0.94 | 0.83 | 0.90 | - |
| Quick Ratio | 0.86 | 0.86 | 1.27 | 1.23 | 1.84 |
| Current Ratio | 1.13 | 1.13 | 1.57 | 1.61 | 2.12 |
| Return on Equity (ROE) | -65.99% | -65.99% | -40.50% | -32.69% | - |
| Return on Assets (ROA) | -13.85% | -13.85% | -5.17% | -5.46% | - |
| Return on Capital (ROIC) | -20.01% | -20.01% | -7.17% | -7.71% | - |
| Earnings Yield | -125.85% | -44.28% | -27.72% | -16.00% | - |
| FCF Yield | -98.33% | -34.68% | -23.00% | -31.70% | - |
| Buyback Yield / Dilution | -73.06% | -73.06% | 0.07% | - | - |
| Total Shareholder Return | -73.06% | -73.06% | 0.07% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.